FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3120182531> ?p ?o ?g. }

• W3120182531 abstract "Background: Chronic obstructive pulmonary disease (COPD) is a major noncommunicable respiratory disease with diverse pulmonary and external pulmonary clinical manifestations. This disease is one of the leading causes of mortality in the world, and about 1% of the adult population suffers from COPD. Objectives: The aim of this study was to assess the effect of Montelukast on the serum level of inflammatory factors in patients with chronic obstructive pulmonary disease (COPD). Methods: In a randomized placebo-controlled trial, 74 patients with COPD with stable conditions were followed for two months after a random assignment to the placebo and montelukast (10 mg/d) groups. All patients continued their treatment protocol irrespective of their group to evaluate the effects of the addition of montelukast on serum levels of common inflammatory factors, such as Tumor Necrosis Factor alpha (TNF-α), C-reactive protein (CRP), and Interleukin 18 (IL-18) in COPD patients. SPSS 18 software was used for data analysis. Results of quantitative data were reported as mean ± standard deviation or median (interquartile range) and qualitative data as frequency (percentage). If the data distribution was normal, the paired t-test was used to compare the mean before and after and using an independent t-test to compare the mean changes between the two groups. The Mann-Whitney U test and Wilcoxon signed-rank test were also used if the data were not assumed to be normal. A P < 0.05 was considered as the level of significance. Results: At baseline, there were no significant differences in laboratory studies between the two groups. After two months of intervention, there was no evidence of decreased TNF-α and CRP in the montelukast group. IL-18 levels were not significantly different at the end of the study between the two groups (P = 0.23), but it had a decreasing trend in the montelukast group (from 20.25 ± 5.98 ng/ml to 16.19 ± 4.17 ng/ml, P < 0.001). Conclusions: Montelukast complementary therapy in COPD patients only improve the serum IL-18 levels and has not a reducing effect on the level of TNF-α and CRP evidenced by keeping their trend from baseline to the end of the study." @default.
• W3120182531 created "2021-01-18" @default.
• W3120182531 creator A5000811866 @default.
• W3120182531 creator A5006760614 @default.
• W3120182531 creator A5031329802 @default.
• W3120182531 creator A5085119973 @default.
• W3120182531 creator A5089468636 @default.
• W3120182531 date "2021-01-03" @default.
• W3120182531 modified "2023-10-14" @default.
• W3120182531 title "A Double-blind Randomized Controlled Trial on the Effects of Montelukast on the Serum Level of Inflammatory Factors in Patients with Chronic Obstructive Pulmonary Disease" @default.
• W3120182531 cites W1610380726 @default.
• W3120182531 cites W1982176636 @default.
• W3120182531 cites W2012728979 @default.
• W3120182531 cites W2027639758 @default.
• W3120182531 cites W2077274868 @default.
• W3120182531 cites W2077813064 @default.
• W3120182531 cites W2080300828 @default.
• W3120182531 cites W2123266507 @default.
• W3120182531 cites W2137740619 @default.
• W3120182531 cites W2138730742 @default.
• W3120182531 cites W2142096203 @default.
• W3120182531 cites W2142501577 @default.
• W3120182531 cites W2153583095 @default.
• W3120182531 cites W2161713331 @default.
• W3120182531 cites W2265301060 @default.
• W3120182531 cites W2313336508 @default.
• W3120182531 cites W2516619135 @default.
• W3120182531 cites W2619076532 @default.
• W3120182531 cites W2915323599 @default.
• W3120182531 cites W2934583654 @default.
• W3120182531 cites W4211090967 @default.
• W3120182531 cites W4254423821 @default.
• W3120182531 doi "https://doi.org/10.5812/semj.104239" @default.
• W3120182531 hasPublicationYear "2021" @default.
• W3120182531 type Work @default.
• W3120182531 sameAs 3120182531 @default.
• W3120182531 citedByCount "0" @default.
• W3120182531 crossrefType "journal-article" @default.
• W3120182531 hasAuthorship W3120182531A5000811866 @default.
• W3120182531 hasAuthorship W3120182531A5006760614 @default.
• W3120182531 hasAuthorship W3120182531A5031329802 @default.
• W3120182531 hasAuthorship W3120182531A5085119973 @default.
• W3120182531 hasAuthorship W3120182531A5089468636 @default.
• W3120182531 hasBestOaLocation W31201825311 @default.
• W3120182531 hasConcept C119060515 @default.
• W3120182531 hasConcept C126322002 @default.
• W3120182531 hasConcept C12868164 @default.
• W3120182531 hasConcept C142724271 @default.
• W3120182531 hasConcept C168563851 @default.
• W3120182531 hasConcept C204787440 @default.
• W3120182531 hasConcept C206041023 @default.
• W3120182531 hasConcept C27081682 @default.
• W3120182531 hasConcept C2776042228 @default.
• W3120182531 hasConcept C2776322731 @default.
• W3120182531 hasConcept C2776780178 @default.
• W3120182531 hasConcept C71924100 @default.
• W3120182531 hasConcept C90924648 @default.
• W3120182531 hasConceptScore W3120182531C119060515 @default.
• W3120182531 hasConceptScore W3120182531C126322002 @default.
• W3120182531 hasConceptScore W3120182531C12868164 @default.
• W3120182531 hasConceptScore W3120182531C142724271 @default.
• W3120182531 hasConceptScore W3120182531C168563851 @default.
• W3120182531 hasConceptScore W3120182531C204787440 @default.
• W3120182531 hasConceptScore W3120182531C206041023 @default.
• W3120182531 hasConceptScore W3120182531C27081682 @default.
• W3120182531 hasConceptScore W3120182531C2776042228 @default.
• W3120182531 hasConceptScore W3120182531C2776322731 @default.
• W3120182531 hasConceptScore W3120182531C2776780178 @default.
• W3120182531 hasConceptScore W3120182531C71924100 @default.
• W3120182531 hasConceptScore W3120182531C90924648 @default.
• W3120182531 hasIssue "6" @default.
• W3120182531 hasLocation W31201825311 @default.
• W3120182531 hasOpenAccess W3120182531 @default.
• W3120182531 hasPrimaryLocation W31201825311 @default.
• W3120182531 hasRelatedWork W2018270163 @default.
• W3120182531 hasRelatedWork W2033836503 @default.
• W3120182531 hasRelatedWork W2061253854 @default.
• W3120182531 hasRelatedWork W2163521166 @default.
• W3120182531 hasRelatedWork W2168449172 @default.
• W3120182531 hasRelatedWork W2286076539 @default.
• W3120182531 hasRelatedWork W2564711576 @default.
• W3120182531 hasRelatedWork W2619141725 @default.
• W3120182531 hasRelatedWork W4306409529 @default.
• W3120182531 hasRelatedWork W4381136618 @default.
• W3120182531 hasVolume "22" @default.
• W3120182531 isParatext "false" @default.
• W3120182531 isRetracted "false" @default.
• W3120182531 magId "3120182531" @default.
• W3120182531 workType "article" @default.